KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Total Non-Current Liabilities (2017 - 2025)

Moderna (MRNA) has disclosed Total Non-Current Liabilities for 9 consecutive years, with $3.4 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities rose 14.43% to $3.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 billion through Dec 2025, up 14.43% year-over-year, with the annual reading at $3.4 billion for FY2025, 14.43% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $3.4 billion at Moderna, up from $2.5 billion in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $10.8 billion in Q3 2021, with the low at $2.3 billion in Q2 2025.
  • Average Total Non-Current Liabilities over 5 years is $5.9 billion, with a median of $4.9 billion recorded in 2023.
  • The sharpest move saw Total Non-Current Liabilities surged 1981.24% in 2021, then tumbled 51.17% in 2023.
  • Over 5 years, Total Non-Current Liabilities stood at $10.4 billion in 2021, then plummeted by 36.83% to $6.6 billion in 2022, then crashed by 34.61% to $4.3 billion in 2023, then crashed by 31.09% to $3.0 billion in 2024, then grew by 14.43% to $3.4 billion in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $3.4 billion, $2.5 billion, and $2.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.